Tergesen, cOO and president of Burcon. The maintenance of the CLARISOY soy proteins patent portfolio during the term of the permit agreement would be the responsibility of Burcon. Today’s announcement marks a watershed development for Burcon as the commercialization of CLARISOY provides Burcon using its first earnings stream. A healthcare facility selected the InCise MLC based on its capability to increase the system's treatment performance and prolong its unique capabilities to a broader selection of patient cases. Evaluation of the InCise MLC with the CyberKnife M6 program has been effectively finished by two U.S.This content was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health Information, an editorially independent information service, is an application of the Kaiser Family members Foundation, a nonpartisan healthcare policy research business unaffiliated with Kaiser Permanente. However, in today’s world food is not just a source of energy and nutrition, it has also became a way to obtain many diseases.